NASDAQ
No price data available for this timeframe.
Seres Therapeutics, Inc. (MCRB) has a current ratio of 2.56x as of Monday, May 25, 2026. This represents a 17.73% increase compared to its 12-month average of 2.17x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.